Fig. 2.
Survival time after intrapericardial carboplatin administration until death or study follow-up. The median survival time from the intrapericardial carboplatin administration until death or study follow-up was 552 days (n = 8)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.